Morning Briefing
Summaries of health policy coverage from major news organizations
FDA, European Regulators, Restrict Avandia Use
In response to data tying the drug to an increased heart attack risk, FDA and European regulators restrict the use of the diabetes drug Avandia.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
